Page last updated: 2024-09-02

fingolimod hydrochloride and indazoles

fingolimod hydrochloride has been researched along with indazoles in 1 studies

Compound Research Comparison

Studies
(fingolimod hydrochloride)
Trials
(fingolimod hydrochloride)
Recent Studies (post-2010)
(fingolimod hydrochloride)
Studies
(indazoles)
Trials
(indazoles)
Recent Studies (post-2010) (indazoles)
2,7711572,0625,6095503,265

Protein Interaction Comparison

ProteinTaxonomyfingolimod hydrochloride (IC50)indazoles (IC50)
Chain A, Cell Division Protein Kinase 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, Cell Division Protein Kinase 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, CELL DIVISION PROTEIN KINASE 2Homo sapiens (human)185
Chain A, Cell Division Protein Kinase 2Homo sapiens (human)185

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dintsios, CM; Rasch, A1

Reviews

1 review(s) available for fingolimod hydrochloride and indazoles

ArticleYear
[Subgroups in the early benefit assessment of pharmaceuticals: a methodical review].
    Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen, 2015, Volume: 109, Issue:1

    Topics: Adenosine; Anilides; Axitinib; Drug Approval; Effect Modifier, Epidemiologic; Fingolimod Hydrochloride; Germany; Humans; Imidazoles; Indazoles; National Health Programs; Pyridines; Risk Assessment; Sitagliptin Phosphate; Sofosbuvir; Ticagrelor

2015